Goat Anti-Mouse IgG (H+L) Fluor594-conjugated - #S0005
| 产品: | Goat Anti-Mouse IgG (H+L) Fluor594-conjugated |
| 货号: | S0005 |
| 来源: | Goat |
| 应用: | WB, IHC, IF/ICC, FACS |
| 反应: | Mouse |
| RRID: | AB_2843435 |
产品描述
来源:
Goat
应用:
WB 1:100-1:500, IHC 1:50-1:200, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user.
*The optimal dilutions should be determined by the end user.
反应:
Mouse
克隆:
Polyclonal
RRID:
AB_2843435
引用格式: Affinity Biosciences Cat# S0005, RRID:AB_2843435.
引用格式: Affinity Biosciences Cat# S0005, RRID:AB_2843435.
偶联:
Fluor594. Ex:591nm/Em:618nm
纯化:
affinity purification.
浓度:
1mg/ml
保存:
0.01M Sodium phosphate, 0.25M NaCl, 50% glycerol, pH7.6.Store at -20℃，avoid repeated thawing and freezing.
抗原和靶标
免疫原:
The antiserum was developed in goat using the MOUSE IgG as the immunogen.
文献引用
1). Targeted long-term noninvasive treatment of choroidal neovascularization by biodegradable nanoparticles. Acta Biomaterialia
(PubMed: 37196903)
[IF=9.4]
2). Implantable 3D Printed Hydrogel Scaffolds Loading Copper-Doxorubicin Complexes for Postoperative Chemo/Chemodynamic Therapy. ACS Applied Materials & Interfaces
(PubMed: 36656977)
[IF=8.3]
3). Up-regulated lncRNA CYLD as a ceRNA of miR-2383 facilitates bovine viral diarrhea virus replication by promoting CYLD expression to counteract RIG-I-mediated type-I IFN production. International journal of biological macromolecules
(PubMed: 37839600)
[IF=7.7]
4). Enhanced Activity against Multi-drug Resistant Bacteria through Coapplication of an Analogue of Tachyplesin I and an Inhibitor of the QseC/B Signaling Pathway. Journal of Medicinal Chemistry
(PubMed: 32003561)
[IF=6.8]
5). Heat promotes melanogenesis by increasing the paracrine effects in keratinocytes via the TRPV3/Ca2+/Hh signaling pathway. iScience
(PubMed: 37216091)
[IF=5.8]
6). Hydrogen gas (H2) delivered by intraperitoneal injection alleviated methionine- and choline-deficient diet-induced metabolic dysfunction-associated steatotic liver disease in mice via inhibiting GSDMD- and GSDME-mediated pyroptosis. Frontiers in pharmacology
(PubMed: 40860880)
[IF=5.6]
7). The protective roles of allicin on type 1 diabetes mellitus through AMPK/mTOR mediated autophagy pathway. Frontiers in Pharmacology
(PubMed: 36817124)
[IF=5.6]
8). Berberine Promotes OATP1B1 Expression and Rosuvastatin Uptake by Inducing Nuclear Translocation of FXR and LXRα. Frontiers in Pharmacology
(PubMed: 32292349)
[IF=5.6]
9). Short-term high-fat diet feeding plus acute ethanol binge induced acute liver injury in mice via oxidative stress, inflammation and pyroptosis. Frontiers in pharmacology
(PubMed: 40606614)
[IF=5.6]
10). Isoquercitrin alleviates pirarubicin-induced cardiotoxicity in vivo and in vitro by inhibiting apoptosis through Phlpp1/AKT/Bcl-2 signaling pathway. Frontiers in pharmacology
(PubMed: 38562460)
[IF=5.6]
限制条款
产品的规格、报价、验证数据请以官网为准，官网链接：www.affbiotech.com | www.affbiotech.cn（简体中文）| www.affbiotech.jp（日本語）产品的数据信息为Affinity所有，未经授权不得收集Affinity官网数据或资料用于商业用途，对抄袭产品数据的行为我们将保留诉诸法律的权利。
产品相关数据会因产品批次、产品检测情况随时调整，如您已订购该产品，请以订购时随货说明书为准，否则请以官网内容为准，官网内容有改动时恕不另行通知。
Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时，请您在Affinity官方渠道提交售后申请。产品仅供科学研究使用。不用于诊断和治疗。
产品未经授权不得转售。
Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.